Duke University Hospital, Investigational Drug Service is a clinical research site located in Durham, North Carolina, United States 27710.
Crixeo Clinical Trials Trust Score: 92/100 (GOOD). This profile has not yet been claimed by the site owner.
Duke University Hospital, Investigational Drug Service has participated in 1 clinical trials.
Therapeutic areas: Sickle Cell Anemia, Sickle Cell Disease, Sickle Cell Disorders.
Sponsors: GlycoMimetics Incorporated.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in North Carolina · View every site in Durham
Trust Score: 92/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Duke University Hospital, Investigational Drug Service has a Crixeo Trust Score of 92/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Duke University Hospital, Investigational Drug Service has 1 clinical trials on record. Their work covers Sickle Cell Anemia, Sickle Cell Disease, Sickle Cell Disorders.
Duke University Hospital, Investigational Drug Service has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.